First TAVR for Aortic Regurgitation Moves to Phase 3 Trial ...Middle East

Medscape - News
The first transcatheter aortic valve replacement device designed specifically to control aortic regurgitation performs well at 2 years in advance of randomized trial, reported investigators. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( First TAVR for Aortic Regurgitation Moves to Phase 3 Trial )

Also on site :